Skip to main content

CAR T-cell Therapy: A Hopeful Option in Cancer Treatment

April 2017

Learn more about:

  • Chimeric antigen receptor (CAR) T-cell therapy as an emerging treatment option
  • The impact of clinical trials in the advancement of treatment for blood cancer patients

Support for this video provided by Juno Therapeutics, Kite Pharma, and Novartis.


< Back to Education Videos